Building Blocks

<p>5-Bromo-2-ethoxypyrimidine is a heterocyclic compound that can be synthesized from 2-ethoxy pyrimidine and bromine. It is a colorless to light yellowish liquid that has a boiling point of 150°C. 5-Bromo-2-ethoxypyrimidine is an alkoxide that can be prepared by the reaction of uracil and perfluoroalkyl acid. It undergoes hydrolysis when treated with acid, forming hydrogen bromide and ethyl cyanoacetate.</p>

<p>4-Methoxy-5-methylpyrimidine is an amide that has been shown to be a potent antagonist of the histamine H1 receptor. It is a structural analogue of suvorexant, which is used as a sedative and hypnotic drug. 4-Methoxy-5-methylpyrimidine can be used in place of suvorexant, but with reduced side effects. This compound also has potential for use as a replacement for other drugs in the same class, such as zolpidem and eszopiclone, since it has similar profiles to these drugs. The chemical structure of 4-methoxy-5-methylpyrimidine is a monocyclic heterocycle that contains two amine groups on one ring and one amine group on the other ring. This compound belongs to the class of pyrimidines and has the chemical formula C6H4N2O3.</p>

<p>3-Bromoadamantane-1-acetic acid is a crystalline solid that has a molecular weight of 168.2 and a melting point of 202°C. It has three polymorphs, with the dihydrate being the most stable form at room temperature. 3-Bromoadamantane-1-acetic acid is an efficacious molecule that can be used to treat bacterial infections as well as fungal infections. This drug also has been shown to have low toxicity in animal studies, with no adverse effects on the liver or kidney observed after repeated administration.</p>

<p>Cyclohexyl(cyclopentyl)methanone is a benzonitrile derivative with a cyclopentyl and cyclohexyl side chain. It can be synthesized by the reaction of phenylmagnesium bromide with methyl benzoate in the presence of sodium borohydride. Cyclohexyl(cyclopentyl)methanone is used as a reagent for the conversion of ketones to aminoketones, and can also be used in hydrolysis reactions involving Grignard reagents.</p>

<p>3-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-purin-7-yl)-propionic acid is a homologous antigen used in the production of theophylline. It is injected into animals to induce immunoprecipitation and albumin conjugation. 3-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-purin-7-yl)-propionic acid is also used as a reagent in the determination of the sensitivity of heterologous antiserum.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(4-Bromophenyl)propan-2-amine (BPAP) is an analogue of the antihistamine diphenhydramine. The BPAP analogues are selective for protein kinases, such as vegfr-2, cyclin, and cdk1. VEGFR-2 is a receptor tyrosine kinase that is activated by vascular endothelial growth factor and plays a role in angiogenesis. Cyclin is a serine/threonine protein kinase that regulates the cell cycle and CDK1 regulates the progression from G1 to S phase. In vivo efficacy studies have shown that BPAP inhibits these three kinases with an IC50 value of less than 1 μM in human tumor cells.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3,4-Dimethyl-2,5-dihydro-1H-pyrrole-2,5-dione is an oxidation product of 2,6-dimethylphenol. It has been shown to crosslink with a matrix polymer and can be used as a bioconjugate in the synthesis of polymers. 3,4-Dimethyl-2,5-dihydro-1H-pyrrole-2,5-dione can react with nitric acid to form nitro groups and it can be used for coating plates or other objects. This compound is also susceptible to UV irradiation and organic solvents.</p>

<p>5,6-Dibromoindoline-2,3-dione is a chemical compound that can be used as an anti-cancer drug. It has been shown to inhibit the activity of histone deacetylase enzymes in vitro and in vivo. 5,6-Dibromoindoline-2,3-dione has also been shown to have potential for use in cancer therapy by inhibiting tyrosine kinases and serotonin receptors. This compound is synthesized from indole and bromine. The chemical reactions involved are hydrogen bonding and substitution reactions.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-(4-Aminophenyl)benzene-1,2-diamine (4-APB) is a neuroprotective agent that has been shown to protect neurons in vitro against oxidative stress and glutamate toxicity. 4-APB also inhibits the uptake of 4-(4-aminophenyl)benzene-1,2-diamine into cells by inhibiting the enzyme responsible for its synthesis. This inhibition leads to a decrease in cellular levels of 4-(4-aminophenyl)benzene-1,2-diamine and an increase in its concentration outside the cell. It has been shown to be effective against human ovarian carcinoma cells and ascitic cancer cells, but not against cisplatin resistant cancer cells. The mechanism of action of this drug is still unknown.</p>

<p>4-Chloro-2H-chromen-2-one is an organic compound that is used as a building block in the synthesis of coumarin derivatives. It undergoes nucleophilic substitution reactions with amines, forming 4-hydroxycoumarin. This reaction is catalyzed by organometallic compounds such as PdCl2 and Cu(OAc)2. Cross-coupling reactions have been shown to be effective for the synthesis of coumarin derivatives. The mechanism of this reaction involves oxidative addition of an organometallic reagent to the carbon atom, followed by elimination of water to form an intermediate epoxide. Deuteration is required for this reaction because hydrogen reacts too rapidly with the organometallic reagents to be useful in the coupling process. 4-Chloro-2H-chromen-2-one has been shown to react with other nucleophiles such as thiols, phenols, and alcohols at</p>

<p>Versatile small molecule scaffold</p>

<p>2-(Prop-2-en-1-ylsulfanyl)benzoic acid is a phenyl group that has the ability to form a desorption molecule. It is light resistant and photopolymerizable, which means it can be used in the production of polymers. The alkylthio group on this molecule allows for transfer and gel permeation chromatography. 2-(Prop-2-en-1-ylsulfanyl)benzoic acid also has a vinylic group, which makes it hydrosilylation crosslinkable. This makes it an excellent candidate for copolymerization and hydrosilylation.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Dimethylaminomethyl-benzoic acid hydrochloride (4DMABAH) is an antiviral agent that inhibits the replication of human immunodeficiency virus type 1 (HIV-1) by blocking the synthesis of viral DNA. 4DMABAH is a prodrug, which is metabolized to its active form, lamivudine, by esterases in the liver and other tissues. 4DMABAH has been shown to be effective against hepatitis B and C viruses in cell culture studies.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>